Secondary HIV Infection and Mitigation in Cure-Related HIV Trials During Analytical Treatment Interruptions

Documenti analoghi

• Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research
  di: Dubé, Karine, et al.
  Pubblicazione: (2021)
• A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption
  di: Peluso, Michael J, et al.
  Pubblicazione: (2020)
• Willingness to risk death endpoint in HIV cure-related research with otherwise healthy volunteers is misleading
  di: Dubé, Karine, et al.
  Pubblicazione: (2020)
• Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach
  di: Peluso, Michael J, et al.
  Pubblicazione: (2020)
• “We Need to Deploy Them Very Thoughtfully and Carefully”: Perceptions of Analytical Treatment Interruptions in HIV Cure Research in the United States—A Qualitative Inquiry
  di: Dubé, Karine, et al.
  Pubblicazione: (2018)